Form 4: Bausch + Lomb Director Boosts Stake with Share Purchase & RSUs

Bausch + Lomb Director Eduardo Alfonso acquired 4,300 common shares and received 4,300 matching restricted share units, increasing his beneficial ownership.

Summary

• Director Eduardo Alfonso purchased 4,300 common shares of Bausch & Lomb Corp (BLCO) on the open market at a price of $17.9 per share on March 2, 2026.
• Concurrently, Mr. Alfonso was granted 4,300 matching restricted share units (MRSUs) at a price of $0, as part of the issuer's matching share program on March 2, 2026.
• Following these transactions, Mr. Alfonso's total beneficial ownership of common shares increased to 13,855.
• The MRSUs will vest in three equal annual installments, with one-third vesting on each of the first, second, and third anniversaries of the grant date, contingent on his continued service.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. An insider purchase, especially coupled with a matching share grant, indicates management confidence and aligns interests, which is generally favorable for investors.

Positives

• Director Eduardo Alfonso increased his direct ownership in the company by purchasing 4,300 common shares on the open market, signaling confidence in the company's future.
• The grant of 4,300 matching restricted share units aligns the director's long-term interests with those of shareholders, as vesting is tied to continued service.

Risks

• The vesting of matching restricted share units is contingent on the reporting person's continued service, meaning forfeiture could occur if service ceases before full vesting.

Future Outlook

The vesting schedule for the matching restricted share units indicates a long-term incentive structure for the director, aligning his interests with the company's performance over the next three years.

Industry Context

StockSavvy.ai notes that insider purchases, especially by directors, are often viewed positively by the market as they can signal management's belief in the company's undervaluation or strong future prospects within the healthcare and vision care industry. The matching share program is a common incentive mechanism to retain key personnel.

Comparison to Industry Standards

• StockSavvy.ai observes that matching share programs and open market purchases by directors are standard practices across various industries, including healthcare. While specific comparable companies or projects are not detailed in this filing, such actions are generally seen as a positive signal, similar to insider buying observed at peers like Alcon (ALC) or CooperCompanies (COO), where management's direct investment often correlates with confidence in long-term growth strategies.

Corporate Governance

Related Party Transactions

• The grant of matching restricted share units to Director Eduardo Alfonso is a transaction between the company and a related party (an insider), conducted under an established matching share program.

Stakeholder Impact

• Shareholders: Increased confidence due to director's investment and alignment of interests.
• Employees: The matching share program could be seen as a positive example of executive compensation and retention strategies.

Next Steps

• One-third of the matching restricted share units will vest on the first anniversary of the grant date (March 2, 2027).
• One-third of the matching restricted share units will vest on the second anniversary of the grant date (March 2, 2028).
• One-third of the matching restricted share units will vest on the third anniversary of the grant date (March 2, 2029).

Key Dates

Recommendation

The director's open market purchase and receipt of matching restricted share units demonstrate a vote of confidence in Bausch & Lomb's future. This insider buying aligns management's interests with shareholders, which is a positive indicator. However, a single insider transaction, while favorable, is generally not sufficient on its own to change a broader investment thesis. Investors should hold and continue to monitor the company's financial performance and strategic developments.

Keywords

Bausch & Lomb, BLCO, Insider Trading, Form 4, Director Share Purchase, Restricted Share Units, Equity Compensation, Share Ownership, Corporate Governance